Navigation Links
Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer

MASON, Ohio, Nov. 11, 2013 /PRNewswire/ -- Aprecia Pharmaceuticals Company ("Aprecia" or "the company") announced today that it has selected Don Wetherhold to serve as the company's next chief executive officer.  Wetherhold previously served as senior vice president, long-term care at Omnicare, Inc.  Prior to his time at Omnicare, Wetherhold was Aprecia's corporate commercialization officer.

"We are thrilled to have Don back at Aprecia, and we look forward to the leadership he will bring to this role," said E. Thomas Arington, Aprecia's chairman.  "Don was instrumental in devising our commercialization strategy at Aprecia.  We are now preparing to file our first product, and we have two additional products in development.  The company is poised for commercial success, and Don's expertise and commitment certainly augment Aprecia's momentum.

"We also know that Don's extensive experience within the healthcare field will serve both him and the company well.  Furthermore, we highly value not only his experience and intelligence but also his character," Arington concluded.

"I'm excited to be back at Aprecia for a number of reasons, not the least of which is the rare opportunity to be the first at something and redefine a market—which is what our breakthrough 3DP product development and manufacturing system has the potential to do," stated Wetherhold.  "Aprecia's technology is being used to enhance the delivery of gold-standard pharmaceutical products, thereby improving treatment adherence for certain patient populations.  The company's vision is to make medicines easier to take, and Aprecia has made great strides toward that vision this past year." 

Wetherhold has 26 years of experience in the healthcare industry, including key management positions and leadership roles at Omnicare, Cardinal Health, Snyder Healthcare Sales, and Solvay Pharmaceuticals.  Prior to his first tenure with Aprecia in 2010, he served as Prasco Laboratories' senior vice president and general manager of Hampton Laine, Prasco's branded pharmaceutical business.

About Aprecia Pharmaceuticals Company – Aprecia is a unique specialty pharmaceutical company built upon an innovative 3DP (three-dimensional printing) technology and manufacturing system.  Aprecia is the first and only company in the world to utilize this technology to develop and manufacture pharmaceutical products at commercial scale. 

CONTACT: Jeff Zurcher
P 513.204.1200

SOURCE Aprecia Pharmaceuticals Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ALCOR Scientific Inc. Welcomes New COO
2. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
3. Cosmetic Dermatology of Orange County Welcomes Worlds Most Advanced Technology for Tattoo Removal
4. Connecticuts CURE network welcomes HLK, its first Chinese member company
5. PurThread Technologies Welcomes Life Sciences Veterans to CEO and Board Positions
6. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
7. SkelRegen Welcomes Director of Scientific Affairs to Management Team
8. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
9. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
10. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
11. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
Post Your Comments:
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):